丹麦乳腺癌晚期复发后的死亡率
基于丹麦乳腺癌协作组等全国数据库,纳入2004-2018年早期或晚期乳腺癌复发且复发后存活6个月的女性,比较早期与晚期复发后的乳腺癌死亡风险。晚期复发患者乳腺癌死亡风险低于早期复发(HR=0.72;95%CI 0.62-0.85),复发部位是主要预后因素。
要点
- 晚期复发(初诊后≥10年)患者10年累积乳腺癌死亡率为50%,早期复发为72%。
- 晚期复发较早期复发的乳腺癌特异性死亡风险降低(HR=0.72;95%CI 0.62-0.85)。
- 复发部位是晚期复发后乳腺癌死亡的主要预后因素。
核心结论
- 晚期复发患者预后优于早期复发患者,复发部位是乳腺癌死亡的主要预后因素。
研究设计与样本
- 利用丹麦乳腺癌协作组及其他全国数据库,纳入2004-2018年早期或晚期乳腺癌复发且复发后存活6个月的女性,随访至乳腺癌死亡、其他原因死亡、移居、10年或2018年12月31日。
主要发现
- 2004例晚期复发患者中721例死于乳腺癌,中位生存时间10年(死亡率=84.8/1000人年;10年累积死亡率=50%)。
- 1528例早期复发患者中1092例死于乳腺癌,中位生存时间4年(死亡率=173.9/1000人年;10年累积死亡率=72%)。
- 晚期复发较早期复发的乳腺癌特异性死亡风险更低(HR=0.72;95%CI 0.62-0.85)。
- 原发诊断时晚期分期、远处转移、局部区域复发的辅助治疗及远处复发的全身治疗与晚期复发后死亡率升高相关。
- 原发诊断时保乳手术、局部区域复发及复发手术与晚期复发后死亡率降低相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Late breast cancer (BC) recurrence (ie, ≥ 10 years after primary diagnosis) may have a more favorable prognosis than earlier recurrence. We investigated the risk of BC death after late recurrence, identified prognostic factors, and compared survival after early and late recurrence. METHODS: Using the Danish Breast Cancer Group and other nationwide databases, we identified women with early or late BC recurrence during 2004-2018, who were alive 6 months after recurrence. We followed them until BC death, death from other causes, emigration, 10 years, or December 31, 2018, whichever came first. We calculated mortality rates (MRs) per 1,000 person-years (PY) and cumulative BC mortality, for early versus late recurrence, and by characteristics of the primary tumor and the late recurrence. Using Cox regression, we calculated adjusted hazard ratios (HRs) for BC death, accounting for death from other causes as competing risks. RESULTS: Among 2,004 patients with late recurrence, 721 died of BC with a median survival time of 10 years (MR = 84.8 per 1,000 PY; 10-year cumulative mortality = 50%). Among 1,528 patients with early recurrence, 1,092 BC deaths occurred with a median survival time of 4 years (MR = 173.9 per 1,000 PY; 10-year cumulative mortality = 72%). We observed a lower hazard of BC-specific death among patients who developed late compared with early recurrence (hazard ratio = 0.72; 95% CI, 0.62 to 0.85). Advanced stage at primary diagnosis, distant metastases, adjuvant treatment for locoregional recurrence, and systemic treatment for distant recurrence were associated with increased mortality after late recurrence. Breast-conserving surgery at primary diagnosis, locoregional recurrence, and surgery for recurrence were associated with lower mortality after late recurrence. CONCLUSION: Patients with late recurrence had more favorable prognosis than patients with early recurrence. The localization of recurrent disease was the main prognostic factor for BC death.
引用
- Pedersen RN, Mellemkjær L, Ejlertsen B, et al. Mortality After Late Breast Cancer Recurrence in Denmark. J Clin Oncol. 2022. PMID: 35171656. doi:10.1200/JCO.21.02062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。